CompanyADCTNYSEEpalinges, V8

ADC Therapeutics SA

ADC Therapeutics develops antibody drug conjugates for oncology.

SEC EDGAR ClinicalTrials.gov ir.adctherapeutics.com

SCHEDULE 13GAug 14Latest SEC filing

Aug 13Latest story

August 2026

ADC Therapeutics reweighs ZYNLONTA path after FDA raises LOTIS-5 safety concerns

Aug 13Regulatory decisionADC Therapeutics SA loncastuximab tesirine

July 2026

ADC Therapeutics grants retention awards to CEO, CFO, CMO

Jul 2PeopleADC Therapeutics SA